Agios Pharmaceuticals (8AP.STU) Q3 2026 Earnings

30JulConfirmed
Q1 2026
Q2 2026
Next
-1.65
-1.58
-1.51
-1.45

Details

Expected EPS
-1.45170399056
Actual EPS
N/A
Surprise EPS
1.45
Surprise Percent
+100%

Description

Agios Pharmaceuticals (8AP.STU) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts